2023-01-25 05:30:00

Sysnav Healthcare announces a multi-year collaboration with Roche based on Sysnav's proprietary movement tracking...

Logo PR Newswire
PR Newswire

VERNON, France, Jan. 25, 2023 /PRNewswire/ -- Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement impairments, as well as designing the next generation of wearable technology based on Sysnav's unique technology.

Patients living with a neuromuscular disorder often suffer from movement impairments that fundamentally impact their daily life. Reliable, objective measurements of a patient's change in motor function can help doctors prescribe the most appropriate therapy and support research aimed to develop new medicines which improve lives. Sysnav Healthcare has developed medical grade wearables based on magneto-inertial technology for 3D movement reconstruction. This enables precise movement tracking without GPS, thus protecting patient privacy while enabling indoor monitoring. Sysnav has already secured the first-ever qualification of a digital endpoint (SV95c) with the European Medicines Agency for Duchenne's Muscular Dystrophy, having worked closely with academic collaborators, patients associations and Roche.

Sysnav Healthcare and Roche have expanded their collaboration across multiple programs to develop meaningful digital endpoints that will monitor disease progression, support clinical trials and serve as regulatory approved standards of outcome measurement. The partnership will also develop the next generation wearable technology to further promote personalised healthcare. "Sysnav's technology offers the opportunity to measure functional disease progression to a regulatory standard across a range of diseases. This has the potential to improve the way patients are involved in clinical studies, the ability to determine potential treatment benefits, and enrich our understanding of disease pathophysiology," says James Sabry, Global Head of Roche Pharma Partnering.

"When high precision technology meets clinical expertise, it is a game-changing combination to accelerate medical progress. Bringing together Sysnav's digital health technology and Roche's expertise in neuroscience drug development and personalised healthcare will enable us to have a truly meaningful impact on patients with motor impairments. By establishing a new set of industry standards for the evaluation of motor impairments, we can unlock innovation for the benefit of all patients," says Damien Eggenspieler, Sysnav Healthcare Program Director.

About Sysnav Healthcare

Sysnav Healthcare is a leading business unit of Sysnav, a fast-growing French independent tech company. Since the start of its activities, Sysnav Healthcare aims to unlock the potential of real-world data in the medical field by adapting extremely precise motion-capture solutions to the needs of healthcare professionals and patients. The company has already developed two wearable devices: ActiMyo® & Syde® and is the first-ever to qualify a digital endpoint (SV95c) with EMA. Sysnav Healthcare, as the pioneer and leader for movement evaluation in clinical trials, is now building the next generation of digital health technologies so that patients benefit earlier and more reliably from life-changing treatments.

For more information, visit: www.healthcare.sysnav.com

Cision View original content:https://www.prnewswire.com/news-releases/sysnav-healthcare-announces-a-multi-year-collaboration-with-roche-based-on-sysnavs-proprietary-movement-tracking-technology-301729991.html

SOURCE Sysnav Healthcare

Logo PR Newswire
TechnologyPress Release2023-01-24 14:00:00
SUNNYVALE, Calif., Jan. 24, 2023 /PRNewswire/ -- NextNav, a leader in next-generation GPS, announced today that STMicroelectronics, a global semiconductor...

Logo PR Newswire
HealthPress Release2023-01-24 14:00:00
Peer-reviewed study validates the first wearable to significantly increase HRV PITTSBURGH, Jan. 24, 2023 /PRNewswire/ -- Today, Apollo Neuroscience®...

Logo EIN Presswire
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2023 TBRCs Cardiovascular Monitoring And Diagnostic Devices And Equipment...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
MALVERN, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on innovative products for hospital and...

Logo PR Newswire
TechnologyPress Release2023-01-24 13:57:00
QuartzBio's suite of end-to-end SaaS solutions provides pharmaceutical and biotech clients with a fully connected data ecosystem linking sample, biomarker,...

Logo PR Newswire
HealthPress Release2023-01-24 12:53:00
MONTREAL, Jan. 24, 2023 /CNW Telbec/ - It is an absolute honor for Sani Sport to be a part of this medical study, which has now been formally published in...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:30:00
Atlas medical technologies GmbH strengthens equity by 2.4 million euros in Series A. The German medical technology company uses the capital increase for...

Logo PR Newswire
HealthPress Release2023-01-24 14:30:00
Atlas medical technologies GmbH strengthens equity by 2.4 million euros in Series A. The German medical technology company uses the capital increase for...

Logo BBC
HealthBy Https://Www Facebook Com/Bbcnews2023-01-24 18:13:43
By Louise Cullen BBC News NI A charity has called for better services for people with motor neurone disease (MND) in Northern Ireland. The fatal neurological...

Logo EIN Presswire
HealthPress Release2023-01-24 09:58:17
Central Patient Monitoring Systems Market Trends Central patient monitoring system is also called a medical monitor, a physiological monitor or a display,...

Logo GlobeNewswire
TechnologyPress Release2023-01-24 14:00:00
FAIRFAX, VA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Futuris Company (OTC Pink: FTRS), a Human Capital Management (HCM) company focused on areas such as Staffing,...

Logo GlobeNewswire
SciencePress Release2023-01-24 17:12:00
Figure 1 PET scans showing mouse brain before (left) and after (right) MS induction (brain encircled in a dashed white line). The enzyme dCK becomes...

Logo PR Newswire
HealthPress Release2023-01-24 08:57:00
Increase in prevalence of spinal cord injury and musculoskeletal disorders and increasing geriatric population suffering from orthopedic disorder drives the...

Logo EIN Presswire
HealthPress Release2023-01-24 11:30:22
Elderly and Disabled Assistive Device Elderly and disabled population are dependent, to a great extent, on other people or devices that support them in their...

Logo EIN Presswire
EntertainmentPress Release2023-01-23 10:28:30
Douglas Insights Bittium, Polar Electro, Oura, Garmin, NeuroMetrix, GOQii, Apple Inc., Samsung, Fitbit, Zephyr Technology Corporation are some of the major...

Logo EIN Presswire
HealthPress Release2023-01-24 16:04:12
Urgent care EKGs help patients stay healthy Providing its patients with a suite of urgent care services in Atlanta, WestsideMed proves that its a staunch...

Logo PR Newswire
HealthPress Release2023-01-24 13:25:00
ASHBURN, Va., Jan. 24, 2023 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a Position Paper entitled "The Importance of...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-23 11:50:00
Four abstracts with clinical data supporting use of Catheter Precision's VIVO technology accepted for presentation at leading electrophysiology conference Ra...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 18:43:00
Biselli joins team dedicated to empowering health systems to embrace an on-demand workforce model that meets the needs of both providers and hospital...

Logo PR Newswire
HealthPress Release2023-01-24 12:17:00
Emerging Market Leader Continues to Execute on Successful Growth Strategy JACKSONVILLE, Fla., Jan. 24, 2023 /PRNewswire/ -- ReviveHealth, a whole health and...